Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17105InvestigationalSmall molecule
Venadaparib: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Poly [ADP-ribose] polymerase 1, Poly [ADP-ribose] polymerase 2, and Poly [ADP-ribose] polymerases
- Formula / weight
- C23H23FN4O2 · 406.461 g/mol (avg)
- Also known as
- 1(2h)-phthalazinone, 4-((3-((3-((cyclopropylamino)methyl)-1-azetidinyl)carbonyl)-4-fluorophenyl)methyl)- · 4-((3-((3-((cyclopropylamino)methyl)-1-azetidinyl)carbonyl)-4-fluorophenyl)methyl)-1(2h)-phthalazinone
Resolves to
Compound
Structure
InChIKey
YNBQAYKYNYRCCA-UHFFFAOYSA-NSMILESFC1=C(C=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1)C(=O)N1CC(CNC2CC2)C1Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with Venadaparib, and which of those have an active Phase 3 trial?